Skip to main content
BioNote, Inc. logo

BioNote, Inc. — Investor Relations & Filings

Ticker · 377740 ISIN · KR7377740006 KO Manufacturing
Filings indexed 160 across all filing types
Latest filing 2022-08-16 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 377740

About BioNote, Inc.

https://www.bionote.com/

BioNote, Inc. is a company specializing in in-vitro diagnostics for the animal health industry. It develops, manufactures, and distributes a range of veterinary diagnostic products, including rapid test kits, ELISA kits, point-of-care (POC) analyzers, and biomarker tests. The company's portfolio is based on its research and development of core biological components like antigens and antibodies. Its products are designed for the detection and diagnosis of animal diseases, providing veterinarians with tools for immunochemical and quantitative analysis in clinical settings.

Recent filings

Filing Released Lang Actions
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'BioNote' (주식회사 바이오노트) covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial information, business descriptions, management discussions, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'BioNote' covering the period from January 1, 2022, to March 31, 2022. It contains detailed financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-16 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Bionote' (주식회사 바이오노트). It includes the independent auditor's report (삼정회계법인), financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. It covers the fiscal years 2020 and 2021. This is a comprehensive financial document, not an earnings release or a simple announcement, and it fits the definition of an Audit Report (AR) as it provides the results of the audit and the financial statements themselves. FY 2021
2022-03-31 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Bionote' (주식회사 바이오노트) covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial data, business operations, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'BioNote' covering the period from 2021.01.01 to 2021.06.30. It contains detailed financial information, business descriptions, management discussions, and capital structure details. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) is classified as an Interim / Quarterly Report (IR). H1 2021
2021-08-17 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'BioNote' (주식회사 바이오노트) for the period ending March 31, 2021. It contains detailed financial statements, including a cash flow statement, management information, and business descriptions. Although it includes a 'correction report' (정정신고) section at the beginning, the document as a whole is a comprehensive quarterly financial filing, which falls under the 'Interim / Quarterly Report' category. Q1 2021
2021-05-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.